You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2+ T cells activities after hematopoietic transplantation for blood malignancies

Article metrics

Article menu

Download PDFPDF

XML
Immune cell therapies and immune cell engineering
Original research
Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2+ T cells activities after hematopoietic transplantation for blood malignancies

 

Online download statistics by month:

Online download statistics by month: March 2020 to May 2023

AbstractFullPdf
Mar 2020898928
Apr 202013613672
May 2020838317
Jun 2020505015
Jul 2020343417
Aug 2020403813
Sep 2020717112
Oct 2020595921
Nov 2020545413
Dec 202040409
Jan 2021656513
Feb 2021555511
Mar 2021737315
Apr 2021626215
May 2021707019
Jun 202149498
Jul 2021535329
Aug 2021525223
Sep 2021656532
Oct 2021575731
Nov 2021606026
Dec 2021646422
Jan 2022566012
Feb 2022465015
Mar 2022747532
Apr 2022818312
May 2022969725
Jun 2022787815
Jul 2022727320
Aug 2022787818
Sep 2022636324
Oct 2022575829
Nov 2022596124
Dec 2022707113
Jan 2023515113
Feb 2023848514
Mar 2023687110
Apr 202355569
Total24692489746